HEPTRA NOVA® | FDA-Approved Liver Support with Resmetirom, TUDCA & NAD+ (Clinically Proven for NAFLD/NASH)

Key Ingredients:

1. Resmetirom: 50mg - A next-gen thyroid hormone receptor-β agonist, Resmetirom directly reduces liver fat and fibrosis by accelerating hepatic lipid metabolism. It improves liver enzymes, reverses steatosis, and reduces cardiovascular risk associated with metabolic liver disease. Resmetirom is the first treatment Approved by FDA for liver cirrhosis, fatty liver and other Liver Problems.
2. TUDCA: 200mg - Tauroursodeoxycholic Acid is a hepatoprotective bile salt that reduces oxidative stress, prevents cell apoptosis, and regenerates liver tissues. It is especially effective in improving bile flow, reducing inflammation, and combating liver fibrosis progression.
3. NAD⁺: 100mg - A crucial coenzyme for mitochondrial repair, NAD⁺ revitalizes cellular metabolism, boosts ATP production, enhances detoxification, and delays liver aging. Essential for patients with metabolic syndrome, chronic fatigue, and liver enzyme abnormalities.

HEPTRA NOVA Key Benefits

• Reduces liver fat and fibrosis
• Improves insulin sensitivity and lipid metabolism
• Promotes hepatocyte regeneration and detoxification
• Supports energy metabolism and mitochondrial health
• Suitable for NAFLD, NASH, and early-stage liver cirrhosis

Dosage:

• Standard: Take 1 capsule twice a day after meals.
• Advanced: Up to 3 capsules/day under clinical guidance.

Duration:

For optimal results, continue for 8-12 weeks and monitor liver enzyme levels periodically.